COMMUNIQUÉS West-GlobeNewswire

Crown Bioscience to Showcase Scientific Expertise at the EORTC-NCI-AACR
06/11/2018
New model data released including Prostate Cancer PDX and humanized target models for the evaluation of combination human checkpoint inhibitors SAN DIEGO, Nov. 06, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, a global [...]
Marrone Bio Innovations Announces International Distribution Partnership with Agricultural Materials Company (AMC-TR) in Turkey
06/11/2018
DAVIS, Calif., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (MBI) (NASDAQ: MBII), a leading global provider of bio-based pest management and plant health products, today announced that it has signed [...]
Insmed to Present at Three November Conferences
06/11/2018
BRIDGEWATER, N.J., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced [...]
Albireo to Report Third Quarter 2018 Financial Results and Host Conference Call and Webcast on November 13, 2018
06/11/2018
BOSTON, Nov. 06, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced that its third quarter [...]
The Crucial Role of Genetics in the Future of the Cannabis Industry -- CFN Media
06/11/2018
SEATTLE, Nov. 06, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article discussing [...]
ATW Tech Announces Signature of a Letter of Intent for Major Acquisition of Greywolf Entertainment Group
06/11/2018
MONTREAL, Nov. 06, 2018 (GLOBE NEWSWIRE) -- ATW Tech Inc. (“ ATW Tech ”) (TSX-V: ATW) announces today the signature of a letter of intent for the acquisition from Fastrack Trust (the “ Trust ”) of all of the outstanding [...]
ATW Tech annonce la signature d’une lettre d’intention pour l’acquisition majeure du Groupe Greywolf Entertainment
06/11/2018
MONTRÉAL, 06 nov. 2018 (GLOBE NEWSWIRE) -- ATW Tech Inc. (« ATW Tech ») ( TSX-V : ATW ), annonce aujourd'hui la signature d’une lettre d’intention visant l’acquisition de la totalité des actions de 6855318 Canada Ltd et [...]
Vaccinex, Inc. to Present Data on Its Semaphorin 4D Monoclonal Antibody Programs at Two Conferences Focused on Cancer Immunotherapy and Huntington’s Disease
06/11/2018
ROCHESTER, N.Y., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company engaged in the discovery and development of targeted biotherapeutics to treat serious diseases and [...]
Early Cannabis Legalization Struggles Could Yield Opportunities -- CFN Media
06/11/2018
SEATTLE, Nov. 06, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
Assure Holdings Sets Third Quarter 2018 Conference Call for Tuesday, November 27, 2018, at 4:30 p.m. ET
06/11/2018
DENVER, Nov. 06, 2018 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (TSXV: IOM; OTC: ARHH), a provider of intraoperative neuromonitoring services, will hold a conference call on Tuesday, November [...]
CytomX Therapeutics Announces CX-072 Clinical Presentations at 2018 SITC Annual Meeting
06/11/2018
PROCLAIM-CX-072 Clinical Translational Data Presented as Poster and Rapid-Fire Oral Presentation Company to Host Analyst and Investor Event and Webcast SOUTH SAN FRANCISCO, Calif., Nov. 06, 2018 (GLOBE NEWSWIRE) -- [...]
Auransa to Participate in BioCentury-BayHelix China Healthcare Summit 2018
06/11/2018
PALO ALTO, Calif., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Auransa, Inc., an artificial intelligence (AI)-driven pharmaceutical company developing precision medicines in areas of significant unmet medical need, today [...]
Bethesda Sedation Dentistry Upgrades to New, State-of-the-Art Office
06/11/2018
The dental practice of Deborah Klotz, DDS and Robert Schlossberg, DDS has moved locations in Bethesda, offering an expanded office space and new technology. BETHESDA, Md., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Dr. Deborah [...]
Sorrento Therapeutics Anti-CEA CAR-T Demonstrates Significant Therapeutic Activity With Increased Overall Survival in Pancreatic Cancer Patients With Liver Metastases
06/11/2018
Two out of four patients showed complete resolution of liver metastases on PET scan Median overall survival (OS) 8.3 months and mean OS 9.8 months, compared to the standard of care 3 to 6 months Meeting scheduled with [...]
Immune Design Announces Multiple G100 Presentations at the Society for Immunotherapy of Cancer Meeting (SITC) Annual Meeting
06/11/2018
New data further support G100’s broad potential in hematological malignancies and solid tumors SEATTLE and SOUTH SAN FRANCISCO, Calif., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Immune Design (Nasdaq: IMDZ), an immunotherapy [...]
Unum Therapeutics to Present Preclinical Data on a New, Emerging Platform Technology for Solid Tumors at the SITC Annual Meeting
06/11/2018
CAMBRIDGE, Mass., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Unum Therapeutics Inc. (NASDAQ: UMRX), today announced that the Company will present preclinical data on a new proprietary technology platform called B olt- O n Chi [...]
East Kent Hospitals goes live with Allscripts PAS
06/11/2018
Another NHS trust in Kent takes the first step on its electronic patient record journey CHICAGO, Nov. 06, 2018 (GLOBE NEWSWIRE) -- East Kent Hospitals University NHS Foundation Trust has gone live with the Allscripts [...]
EDAP TMS SA : EDAP TMS SA to Announce Third Quarter 2018 Financial Results on Wednesday, November 14
06/11/2018
LYON, France, November 6, 2018 - EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced that it will release its financial results for the third quarter and nine months ended September [...]
Jounce Therapeutics to Announce Third Quarter 2018 Financial Results and Host Conference Call on Tuesday, November 13, 2018
06/11/2018
CAMBRIDGE, Mass., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, [...]

Pages